Quantitative 3T MR Imaging of the Descending Thoracic Aorta: Patients with Familial Hypercholesterolemia Have an Increased Aortic Plaque Burden Despite Long-Term Lipid-lowering Therapy

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 10, 2008, Pages 1403-1408

  Schmitz, Stephan A ^a   O'Regan, Declan P ^a   Fitzpatrick, Julie ^a   Neuwirth, Clare ^a,b   Potter, Elizabeth ^a,b   Tosi, Isabella ^a,b   Hajnal, Joseph V ^a   Naoumova, Rossi P ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; ROSUVASTATIN;

ADULT; AORTA ATHEROSCLEROSIS; ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THORACIC AORTA;

ADULT; AGED; ANTILIPEMIC AGENTS; AORTA, THORACIC; AORTIC VALVE STENOSIS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 52149110137     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.06.020     Document Type: Article

References (30)

1. Hofmann L.V., Liddell R.P., Arepally A., Montague B., Yang X., and Bluemke D.A. In vivo intravascular MR imaging: transvenous technique for arterial wall imaging. J Vasc Interv Radiol 14 (2003) 1317-1327
2. Meissner O.A., Rieger J., Rieber J., et al. High-resolution MR imaging of human atherosclerotic femoral arteries in vivo: validation with intravascular ultrasound. J Vasc Interv Radiol 14 (2003) 227-231
3. Wyttenbach R., Gallino A., Alerci M., et al. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 110 (2004) 1156-1161
4. Moody A.R., Murphy R.E., Morgan P.S., et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107 (2003) 3047-3052
5. Hatsukami T.S., Ross R., Polissar N.L., and Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102 (2000) 959-964
6. Schmitz S.A., O'Regan D.P., Gibson D., et al. Technical report: magnetic resonance direct thrombus imaging at 3 T field strength in patients with lower limb deep vein thrombosis-a feasibility study. Clin Radiol 61 (2006) 282-286
7. Amann-Vesti B.R., Kozerke S., Krieger E., Boesiger P., and Koppensteiner R. High wall shear stress measured by magnetic resonance is a predictor of restenosis in the femoral artery after balloon angioplasty. Int Angiol 23 (2004) 270-275
8. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 (1995) 1301-1307
9. 4S-Study-Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
10. Mercuri M., Bond M.G., Sirtori C.R., et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 101 (1996) 627-634
11. Zhao X.Q., Yuan C., Hatsukami T.S., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 21 (2001) 1623-1629
12. Takagi T., Yoshida K., Akasaka T., Hozumi T., Morioka S., and Yoshikawa J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol 79 (1997) 1673-1676
13. Corti R., Fuster V., Fayad Z.A., et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 46 (2005) 106-112
14. Lima J.A., Desai M.Y., Steen H., Warren W.P., Gautam S., and Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110 (2004) 2336-2341
15. Yonemura A., Momiyama Y., Fayad Z.A., et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 45 (2005) 733-742
16. Stone N.J., Levy R.I., Fredrickson D.S., and Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 49 (1974) 476-488
17. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet 2 (1969) 1380-1382
18. Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., and Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet 357 (2001) 577-581
19. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis 142 (1999) 105-112
20. Neil H.A., Hammond T., Huxley R., Matthews D.R., and Humphries S.E. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ 321 (2000) 148
21. Tosi I., Toledo-Leiva P., Neuwirth C., Naoumova R.P., and Soutar A.K. Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic. Atherosclerosis 194 (2007) 102-111
22. Huxley R.R., Hawkins M.H., Humphries S.E., Karpe F., and Neil H.A. Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study. Stroke 34 (2003) 22-25
23. Hoeg J.M., Feuerstein I.M., and Tucker E.E. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 14 (1994) 1066-1074
24. Goldstein J., Hobbs H., and Brown M. Familial hypercholesterolaemia. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The metabolic and molecular basis of inherited disorders. 7th ed. (1994), McGraw Hill, New York, NY 1981-2030
25. Neil H.A., Huxley R.R., Hawkins M.M., Durrington P.N., Betteridge D.J., and Humphries S.E. Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study. Atherosclerosis 170 (2003) 73-78
26. Aikawa M., Rabkin E., Sugiyama S., et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103 (2001) 276-283
27. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
28. Yuan C., Beach K.W., Smith Jr. L.H., and Hatsukami T.S. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 98 (1998) 2666-2671
29. Yuan C., Mitsumori L.M., Ferguson M.S., et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104 (2001) 2051-2056
30. Li A.E., Kamel I., Rando F., et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. AJR Am J Roentgenol 182 (2004) 593-597